Pressed for time? Here's the medtech news you need most, in one minute or less.

The federal government presents a lucrative and important market opportunity for medical device companies.

Dr. Dave Albert, the co-founder and CMO of AliveCor, sat down with Let’s Talk Medtech to discuss recent FDA clearances; the state of the ECG monitoring market; and the explosion of telehealth.

Trained dogs can detect cancer and other diseases through smell. Now, a miniaturized detector can analyze trace molecules to mimic the process

RhythMedix is the latest company to make moves in the space. The firm announced launching its next-generation wearable cardiac monitor that has built-in cellular connectivity.

FDA’s Jeff Shuren, MD, and Timothy Stenzel, MD, discussed the flaws of the antibody testing guidance in a recently published editorial in The New England Journal of Medicine.

The company appears to be making haste to put a leadership team in place as it prepares to spin off its spine and dental businesses into a new public company.

Revisions were made to guidelines for laser safety, electrosurgical safety, pneumatic tourniquet safety, instrument care and cleaning, care of the patient receiving local-only anesthesia, and specimen management.

Guardant Health has launched a blood-only liquid biopsy test for the detection of residual and recurrent colorectal cancer.